Kvantify key facts
as of Oct 2026- Developer of a healthcare platform designed to solve computational challenges in drug discovery.
- Kvantify is valued at approximately $21.4M as of Oct 2026 (last reported valuation).
- It has raised $70.4M; the latest was Early Stage VC ($52.2M) in Mar 2026.
- Notable investors include European Innovation Council, Denmark's Export and Investment Fund, Nordic Mentor Network For Entrepreneurship, QAI Ventures, Future Five — 14 tracked in total.
- Status: Privately Held (backing).
Kvantify's last reported valuation, Jul 2024. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Kvantify: the Monday email on marks, rounds and moves
Kvantify funding rounds
No funding rounds for Kvantify are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Kvantify
14+Kvantify valuation
Kvantify's last reported valuation was $21.4 million in Jul 2024. No priced round, secondary trade or fund mark has surfaced since.
Kvantify investors
14 investors are on record for Kvantify, including European Innovation Council, Denmark's Export and Investment Fund, Nordic Mentor Network For Entrepreneurship and QAI Ventures.
About Kvantify
Developer of a healthcare platform designed to solve computational challenges in drug discovery. The company's platform facilitates computational drug technology to improve the quality of compounds tested in the lab by leveraging proprietary, accurate physics-based methods, enabling life sciences companies to accelerate small molecule research and deliver actionable results that make a difference.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2022
- Employees
- 60
- Website
- kvantify.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.